Purpose: Parkinson disease (PD) is a progressive neurodegenerative disease. The aim of this study is to investigate the association between acoustic and cortical brain features in Parkinson's disease patients.

Methods: We recruited 19 (eight females, 11 males) Parkinson's disease patients and 19 (eight females, 11 males) healthy subjects to participate in the experiment. Speech samples of three vowels (/i/, /a/, /u/), six plosives (/p/, /pʰ/, /t/, /tʰ/, /k/, /kʰ/), and three voiced consonants (/l/, /m/, /n/) were collected for the experiment, and the acoustic parameters were extracted for fundamental frequency (F0), voice onset time (VOT), voicing onset-vocalic voicing onset (VO-VVO), first formant (F1), second formant (F2), third formant (F3), first bandwidth (B1), second bandwidth (B2), third bandwidth (B3), Jitter, Shimmer, and Harmonics-to-noise ratio (HNR). We also used Ingenia CX 3.0 T to complete the cranial magnetic resonance scanning and did image processing based on the Desikan-Killiany-Tourville Atlas. We assessed the differences in acoustic and neuroimaging parameters between the PD and healthy controls (HCs) groups using the Levene's test (LT), two-sample independent t test (TT), and Mann-Whitney U test (MWUT), and calculated Spearman's bias correlations for acoustic and neuroimaging parameters in the PD and HC groups, respectively.

Results: The results showed that in acoustic features, based on the results of the TT, it can be seen that the F3 of the PD group regarding the vowel /i/ is significantly smaller than that of the HC group. The jitter on the vowel /u/ was significantly higher in the male PD group than in the male HC group. For other acoustic measures, there were no statistically significant differences between the two groups. In the cortical features, the thickness, area, and volume of the cortex were reduced in the vast majority of the brains of the PD patients, however, there is also a small portion of the cortex that appears to be thickened. In the correlation analysis between cortical and acoustic features, F0, F1, F2, F3, B2, B3, VO-VVO, Jitter, HNR, and VOT acoustic parameters showed significant and strong correlation with thickness, area, and volume of cortical sites such as frontal, temporal, entorhinal, fusiform, and precuneus in PD patients, whereas no significant correlation was found in HC group.

Conclusions: This suggests that Parkinson's disease does have an effect on the acoustic and cortical features of the patient's brain, and that there is a correlation between the two features.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvoice.2024.11.042DOI Listing

Publication Analysis

Top Keywords

parkinson's disease
16
acoustic features
12
acoustic
10
correlation analysis
8
analysis cortical
8
features
8
acoustic cortical
8
females males
8
acoustic parameters
8
acoustic neuroimaging
8

Similar Publications

Objective: The purpose of study was to explore family caregiver perspectives on work-life balance while caring for adults with Parkinson's Disease.

Methods: The study was performed using a convergent mixed methods design and a revised adaptation of the Work-Life Conflict model. Caregivers completed surveys followed by semi-structured interviews (N = 40).

View Article and Find Full Text PDF

Introduction: Adjunctive therapies to treat OFF episodes resulting from long-term levodopa treatment in Parkinson disease (PD) are hampered by safety and tolerability issues. Istradefylline offers an alternative mechanism (adenosine A2A receptor antagonist) and therefore potentially improved tolerability.

Methods: A systematic review of PD adjuncts published in 2011 was updated to include randomized controlled trials published from January 1, 2010-April 15, 2019.

View Article and Find Full Text PDF

Pathophysiological Significance of α-Synuclein in Sympathetic Nerves: In Vivo Observations.

Neurology

February 2025

From the Autonomic Medicine Section, Clinical Neurosciences Program, Division of Intramural Research, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD.

Background And Objectives: Lewy body diseases (LBDs) such as Parkinson disease (PD) feature increased deposition of α-synuclein (α-syn) in cutaneous sympathetic noradrenergic nerves. The pathophysiologic significance of sympathetic intraneuronal α-syn is unclear. We reviewed data about immunoreactive α-syn, tyrosine hydroxylase (TH, a marker of catecholaminergic fibers), and the sympathetic neurotransmitter norepinephrine (NE) in skin biopsies from control participants and patients with PD, the related LBD pure autonomic failure (PAF), the non-LBD synucleinopathy multiple system atrophy (MSA), or neurologic postacute sequelae of severe acute respiratory syndrome coronavirus 2 (neuro-PASC).

View Article and Find Full Text PDF

Molecular Determinants of Protein Pathogenicity at the Single-Aggregate Level.

Adv Sci (Weinh)

January 2025

Sheffield Institute for Translational Neuroscience, Division of Neuroscience, University of Sheffield, Sheffield, S10 2HQ, UK.

Determining the structure-function relationships of protein aggregates is a fundamental challenge in biology. These aggregates, whether formed in vitro, within cells, or in living organisms, present significant heterogeneity in their molecular features such as size, structure, and composition, making it difficult to determine how their structure influences their functions. Interpreting how these molecular features translate into functional roles is crucial for understanding cellular homeostasis and the pathogenesis of various debilitating diseases like Alzheimer's and Parkinson's.

View Article and Find Full Text PDF

Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent Inhibitor.

J Proteome Res

January 2025

Target Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, U.K.

Inhibition of the mitochondrial deubiquitinating (DUB) enzyme USP30 is neuroprotective and presents therapeutic opportunities for the treatment of idiopathic Parkinson's disease and mitophagy-related disorders. We integrated structural and quantitative proteomics with biochemical assays to decipher the mode of action of covalent USP30 inhibition by a small-molecule containing a cyanopyrrolidine reactive group, . The inhibitor demonstrated high potency and selectivity for endogenous USP30 in neuroblastoma cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!